Research Article
Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer
Figure 2
Model (13) (without immune suppressors): the effector cells overcome the development of cancer cells as a result of the stimulation and activation by the BCG .